Beigene, Ltd. (BGNE): Donald W. Glazer , director of Beigene, Ltd. sold 67,252 shares on Sep 19, 2016. The Insider selling transaction was reported by the company on Sep 21, 2016 to the Securities and Exchange Commission. The shares were sold at $31.48 per share for a total value of $2,113,060.75 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Feb 10, 2016, Capital Management, Hillhouse (10% owner) purchased 9,100,000 shares at $0.00 per share price.On Feb 9, 2016, Howard Liang (CFO) purchased 65,000 shares at $1.85 per share price.Also, On Feb 9, 2016, Ruirong Yuan (Chief Medical Officer) purchased 130,000 shares at $1.85 per share price.
Company has been under the radar of several Street Analysts.Beigene, Ltd. is Initiated by Maxim Group to Buy and the brokerage firm has set the Price Target at $41. The Rating was issued on Sep 22, 2016.